Local media reported on the 10th that South Africa’s Health Minister Mukez said that the first phase of South Africa’s coronavirus vaccination program is expected to begin next week, but no specific details can be disclosed at present.
This week, the South African government had to stop the AstraZeneca vaccine originally scheduled for this week, because research shows that the vaccine has limited protection for people with mild to moderate symptoms of mutant COVID-19.
Mukez said that the country will use the coronavirus vaccine produced by Johnson & Johnson and Pfizer in the first phase, and South African medical staff will be given priority.
At present, the South African government is negotiating with Johnson & Johnson for a final payment.
